Search company, investor...

Slipper Limpet Processing

Stage

Growth Equity | Alive

Total Raised

$970K

Last Raised

$970K | 8 yrs ago

About Slipper Limpet Processing

Provider of slipper limpets. The company has developed a system designed to separate the skin from the shell of slipper limpets, a marine mollusk. Slipper limpets are aimed at the agribusiness and healthcare industry.

Headquarters Location

6 lotissement de Vauhariot

Cancale, 35260,

France

33 6 07 56 61 48

Missing: Slipper Limpet Processing's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Slipper Limpet Processing's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Slipper Limpet Processing Frequently Asked Questions (FAQ)

  • Where is Slipper Limpet Processing's headquarters?

    Slipper Limpet Processing's headquarters is located at 6 lotissement de Vauhariot, Cancale.

  • What is Slipper Limpet Processing's latest funding round?

    Slipper Limpet Processing's latest funding round is Growth Equity.

  • How much did Slipper Limpet Processing raise?

    Slipper Limpet Processing raised a total of $970K.

  • Who are the investors of Slipper Limpet Processing?

    Investors of Slipper Limpet Processing include Business Angels 35.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.